WATSON 335 (Acyclovir 400 mg)
Pill imprint WATSON 335 has been identified as Acyclovir 400 mg.
Acyclovir is used in the treatment of herpes simplex, suppression; herpes simplex; ramsay hunt syndrome; herpes simplex, mucocutaneous/immunocompromised host; herpes simplex encephalitis (and more), and belongs to the drug class purine nucleosides. There is no proven risk in humans during pregnancy. Acyclovir 400 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 335
- 400 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Purine nucleosides
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|54569-4765||A S Medication Solutions LLC (repackager)|
|54868-3997||Physicians Total Care Inc (repackager)|
|55887-0246||Diversified Healthcare Services Inc (repackager)|
|13411-0182||Advanced Pharmaceutical Services Inc (repackager)|
|63874-0500||Altura Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about acyclovir
- Acyclovir capsules
- Acyclovir suspension
- Acyclovir tablets
- Acyclovir injection
- Acyclovir Oral, Intravenous (Advanced Reading)
- Other brands: Zovirax
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.